Vera Therapeutics, Inc. (VERA)
34.04
-0.31
(-0.90%)
USD |
NASDAQ |
May 22, 16:00
33.88
-0.16
(-0.47%)
Pre-Market: 20:00
Vera Therapeutics Total Assets (Quarterly) : 621.74M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 903.01M |
| Syndax Pharmaceuticals, Inc. | 472.67M |
| United Therapeutics Corp. | 6.714B |
| Biogen, Inc. | 29.48B |
| Cytokinetics, Inc. | 1.273B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 122.04M |
| Shareholders Equity (Quarterly) | 499.70M |
| Debt to Equity Ratio | 0.1501 |
| Current Ratio | 13.47 |
| Net Debt Paydown Yield | -0.14% |